UI Investissement
UI Investissement, formerly known as UI Gestion SAS, is a private equity and venture capital firm established in 2004 and headquartered in Paris, France. The firm specializes in investments in small to mid-cap companies across various sectors, with a particular focus on healthcare, agri-food, and services industries. Over the years, UI Investissement has actively supported the growth of more than 120 small and medium-sized enterprises, investing over €550 million in their development projects. The firm aims to finance a wide range of business stages, including seed, startup, and growth capital, as well as buyouts and turnaround transactions. Its investment strategy is regionally focused, primarily targeting areas in France such as Aquitaine, Brittany, and Ile-de-France, and it typically invests between €1 million and €50 million depending on the enterprise value of the companies. UI Investissement aims to act as both a majority and minority shareholder, leveraging its experience and corporate culture to foster sustainable performance in its portfolio companies.
Past deals in Paris
AdEchoTech
Venture Round in 2024
AdEchoTech is a French company based near Paris, established in 2008 by Dr. Éric Lefebvre, a distinguished ultrasound radiologist with over 25 years of expertise. The company focuses on developing remote ultrasonography devices aimed at addressing medical desertification and the lack of healthcare services in underserved areas. AdEchoTech specializes in the design, manufacture, and marketing of robotic ultrasound equipment that facilitates abdominal, cardiac, pelvic, urinary tract, and gynecologic imaging. By integrating input from the medical community during the early design stages, the company ensures its solutions effectively meet the needs of healthcare providers. This approach enhances patient care, reduces transportation costs, and increases the availability of sonographers, ultimately contributing to improved public health outcomes. Dr. Lefebvre serves as the President of the company while continuing to practice radiology, aligning the company's innovations with the current demands of the biomedical field.
Acticor Biotech
Post in 2024
Acticor Biotech SAS is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing innovative therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the critical need for new therapeutic options in the management of stroke, a condition that affects millions globally each year and leads to significant mortality and disability. Currently, existing treatments for ischemic stroke have limited efficacy and reach, highlighting the urgent demand for more effective solutions. Acticor Biotech is dedicated to advancing its novel therapies to meet this pressing medical need.
Geosophy
Venture Round in 2023
Geosophy is a Paris-based company founded in 2018 that specializes in the development of real estate assets and the management of energy usage for thermal comfort. The company focuses on assessing the geo-energy potential for the sustainable heating and cooling of buildings. Geosophy creates software tools that utilize data science and machine learning techniques to automate and enhance the feasibility studies of geo-energy installations. These tools aid building owners in developing physics and financial models, ultimately enabling them to maximize the value of their geo-energy resources.
Cocolis
Private Equity Round in 2021
Cocolis is a Paris-based company, founded in 2015, that specializes in online shipping solutions for heavy or bulky items. It connects individuals who need to send goods with drivers who have available space in their vehicles. By facilitating co-transportation, Cocolis offers a cost-effective alternative for shipping, allowing clients to benefit from reduced shipping fees or reimbursement for transport costs. The company aims to streamline the logistics of parcel delivery while promoting efficient use of vehicle space.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.